554 related articles for article (PubMed ID: 8934059)
21. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
Gaspard UJ; Dubois M; Gillain D; Franchimont P; Duvivier J
Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K; Lunell NO; Zador G
Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
[TBL] [Abstract][Full Text] [Related]
23. The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days.
Csemiczky G; Dieben T; Coeling Bennink HJ; Landgren BM
Contraception; 1996 Dec; 54(6):333-8. PubMed ID: 8968661
[TBL] [Abstract][Full Text] [Related]
24. Ovarian function during low-dose oral contraceptive use.
Egarter C; Putz M; Strohmer H; Speiser P; Wenzl R; Huber J
Contraception; 1995 Jun; 51(6):329-33. PubMed ID: 7554971
[TBL] [Abstract][Full Text] [Related]
25. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels.
Kuhl H; Gahn G; Romberg G; März W; Taubert HD
Contraception; 1985 Jun; 31(6):583-93. PubMed ID: 2931247
[TBL] [Abstract][Full Text] [Related]
26. Ultrasound evaluation of ovarian activity under oral contraceptives.
Hoogland HJ; Skouby SO
Contraception; 1993 Jun; 47(6):583-90. PubMed ID: 8334892
[TBL] [Abstract][Full Text] [Related]
27. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
28. Serum gonadotropin and ovarian steroid levels in women during administration of a norethindrone-ethinylestradiol triphasic oral contraceptive.
Ling WY; Johnston DW; Lea RH; Bent AE; Scott JZ; Toews MR
Contraception; 1985 Oct; 32(4):367-75. PubMed ID: 3935373
[TBL] [Abstract][Full Text] [Related]
29. Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity.
Sullivan H; Furniss H; Spona J; Elstein M
Fertil Steril; 1999 Jul; 72(1):115-20. PubMed ID: 10428158
[TBL] [Abstract][Full Text] [Related]
30. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K
Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
[TBL] [Abstract][Full Text] [Related]
31. Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial.
Seidman L; Kroll R; Howard B; Ricciotti N; Hsieh J; Weiss H
Contraception; 2015 Jun; 91(6):495-502. PubMed ID: 25746294
[TBL] [Abstract][Full Text] [Related]
32. Dimeric inhibin serum values as markers of ovarian activity in pill-free intervals.
Renier MA; Vereecken A; Van Herck E; Straetmans D; Ramaekers P; Vanderheyden J; Degezelle H; Buytaert P
Contraception; 1998 Jan; 57(1):45-8. PubMed ID: 9554250
[TBL] [Abstract][Full Text] [Related]
33. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
Croxatto HB; Massai MR; Salvatierra AM; Fuentealba B; Croxatto HD; Lähteenmäki P
Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
[TBL] [Abstract][Full Text] [Related]
34. Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 microgram ethinyl estradiol combined with 150 microgram desogestrel or 75 microgram gestodene.
Zichella L; Sbrignadello C; Tomassini A; Di Lieto A; Montoneri C; Zarbo G; Mancone M; Pietrobattista P; Bertoli G; Perrone G
Adv Contracept; 1999; 15(3):191-200. PubMed ID: 11019950
[TBL] [Abstract][Full Text] [Related]
35. Ovarian follicles during oral contraceptive cycles: their potential for ovulation.
Killick SR
Fertil Steril; 1989 Oct; 52(4):580-2. PubMed ID: 2680616
[TBL] [Abstract][Full Text] [Related]
36. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
Hammerstein J; Daume E; Simon A; Winkler UH; Schindler AE; Back DJ; Ward S; Neiss A
Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.
Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
J Assist Reprod Genet; 1998 Nov; 15(10):599-604. PubMed ID: 9866068
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol.
Archer DF; Timmer CJ; Lammers P
Fertil Steril; 1994 Apr; 61(4):645-51. PubMed ID: 8150105
[TBL] [Abstract][Full Text] [Related]
39. The effect of norethisterone (500 mcg) and ethinyl estradiol (35 mcg) capsules on the pituitary-ovarian axis.
Nuttall ID; Elstein M; Fahmy DR
Contraception; 1982 May; 25(5):463-9. PubMed ID: 6809424
[TBL] [Abstract][Full Text] [Related]
40. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
